Metafoodx | $9,400,000 | (May 16, 2025)
Ascendx | $110,000,000 | (May 16, 2025)
Algoma | $2,300,000 | (May 16, 2025)
Certified by Founder
Lodge
CellFE
start up
United States
- Alameda, California
- 28/09/2023
- Series A
- $22,000,000
CellFE is a cell engineering startup that enables development and manufacturing of the new generation of medicines – cell therapies. CellFE has developed a unique microfluidic platform to solve one of the most pressing issues of therapeutic cell engineering –efficiently delivering gene-editing molecules into cells while preserving cell viability. CellFE’s technology:
• Enables development of previously inaccessible cell therapies by providing means for transporting hard-to-deliver molecules into the cells.
• Accelerates commercialization of existing cell therapies by significantly reducing cost, complexity, and processing time, while improving the efficacy and safety of the cell engineering process.
- Industry Biotechnology
- Website https://www.cellfebiotech.com/
- LinkedIn https://www.linkedin.com/company/cellfe-biotech/about/
Plakar | $3,000,000 | (May 16, 2025)
Solestial, Inc. | $17,000,000 | (May 16, 2025)
Adyton PBC | $11,000,000 | (May 16, 2025)
Sproutr | Undisclosed Amount | (May 16, 2025)
Voltra | $1,800,000 | (May 16, 2025)
IMPRINT(US) | $15,000,000 | (May 16, 2025)
Sprinter Health | $55,000,000 | (May 16, 2025)
CarbonSix | $4,000,000 | (May 16, 2025)
Zeno Power | $50,000,000 | (May 16, 2025)